News
Latest News
New Trials in Lung Cancer: Could Your Patients Benefit?
A number of lung cancer trials are recruiting for NSCLC which is locally advanced, metastatic, and with or without mutations.
Commentary
Is This Journal Legit? Predatory Publishers
Physicians discuss various publishing models, and what journal characteristics to look out for as predatory.
Conference Coverage
Platinum Add-On Improves Survival in Early TNBC
Trial outcomes provide strong evidence for incorporating carboplatin into both the neoadjuvant and adjuvant settings in patients with early-stage...
Conference Coverage
Should ctDNA guide clinical decisions in GI cancers?
Data are maturing for colon cancer and emerging for pancreatic cancer, but experts say more work needs to be done.
Latest News
Rethinking Management of Skin Cancer in Older Patients
The dermatologist's risk assessment -- both staging and stratifying risk as it relates to specific outcomes such as recurrence, metastases, or...
News
New Clues on How Blast Exposure May Lead to Alzheimer’s Disease
A higher index of suspicion for dementia or Alzheimer’s disease may be warranted in patients with a history of blast exposure or subconcussive...
Conference Coverage
Migraine Linked to Cardiovascular Risk in Veterans Study
A Veterans Administration study of migraine found a greater risk of stroke and TIA and a reduced risk of hemorrhagic stroke in men.
Latest News
OTC Supplement Linked to Hyperpigmentation
CHICAGO —“Many of our patients think kratom is a safe, herbal supplement” but often don’t know it can have several...
Conference Coverage
Lung Cancer Expert at ASCO: From Fatal to ‘Chronic Disease’
Tony Shu-Kam Mok, MD, discusses latest KRAS G12C findings and more.
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...